Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome

The Graduate University for Advanced Studies, SOKENDAI

PubMed
Indexed incrossrefpubmed

Abstract

In this study, we defined the role of peroxisome proliferator-activated receptor beta/delta (PPARdelta) in metabolic homeostasis by using subtype selective agonists. Analysis of rat L6 myotubes treated with the PPARdelta subtype-selective agonist, GW501516, by the Affymetrix oligonucleotide microarrays revealed that PPARdelta controls fatty acid oxidation by regulating genes involved in fatty acid transport, beta-oxidation, and mitochondrial respiration. Similar PPARdelta-mediated gene activation was observed in the skeletal muscle of GW501516-treated mice. Accordingly, GW501516 treatment induced fatty acid beta-oxidation in L6 myotubes as well as in mouse skeletal muscles. Administration of GW501516 to mice…

Citation impact

824
total citations
FWCI
16.03
Percentile
100%
References
19
Citations per year

Authors

22

Topics & keywords

Keywords
  • Endocrinology
  • Internal medicine
  • Beta oxidation
  • Peroxisome
  • Skeletal muscle
  • Peroxisome proliferator-activated receptor
  • Insulin resistance
  • Fatty acid
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.